Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Arbuckle Stuart A Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Arbuckle Stuart A (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 827 shares @ $15.87, valued at $13.1k
07/05/2023 4 Arbuckle Stuart A (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 695 shares @ $18.87, valued at $13.1k
06/16/2023 4 Arbuckle Stuart A (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 13,090 restricted stock units @ $0
Granted 19,597 options to buy @ $0
06/01/2023 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 82 shares @ $329.82, valued at $27k
02/28/2023 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 4,714 shares @ $289.12, valued at $1.4M
Sold 3,834 shares @ $287.16, valued at $1.1M
Sold 400 shares @ $287.59, valued at $115k
Sold 800 shares @ $288.92, valued at $231.1k
02/24/2023 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 129 shares @ $291.84, valued at $37.6k
Sold 300 shares @ $292.86, valued at $87.9k
Sold 1,378 shares @ $294.29, valued at $405.5k
Sold 394 shares @ $295.38, valued at $116.4k
Sold 200 shares @ $296.31, valued at $59.3k
02/22/2023 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 4,498 shares @ $292.85, valued at $1.3M
Sold 21 shares @ $291.01, valued at $6.1k
Sold 545 shares @ $292.77, valued at $159.6k
Sold 1,100 shares @ $293.74, valued at $323.1k
Sold 736 shares @ $294.58, valued at $216.8k
02/14/2023 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 3,372 shares @ $294.33, valued at $992.5k
Paid exercise price by delivering 5,990 shares @ $298.26, valued at $1.8M
Sold 245 shares @ $296.44, valued at $72.6k
Sold 2,028 shares @ $298.42, valued at $605.2k
Sold 1,779 shares @ $299.26, valued at $532.4k
Sold 835 shares @ $300.13, valued at $250.6k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 3,040 shares @ $237.74, valued at $722.7k
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2021 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2 shares @ $186.99, valued at $374
Sold 1 shares @ $187.8, valued at $187.8
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2020 4 Arbuckle Stuart A (EVP, Chief Commercial Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2 shares @ $222.47, valued at $444.9
Sold 5 shares @ $224.11, valued at $1.1k
11/05/2020 4 Arbuckle Stuart A (EVP, Chief Commercial Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 487 shares @ $210.56, valued at $102.5k
Sold 487 shares @ $211.54, valued at $103k
Sold 245 shares @ $212.38, valued at $52k
Sold 334 shares @ $214.13, valued at $71.5k
Exercised 1,553 options to buy @ $86.52, valued at $134.4k
08/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/09/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy